P.V. Glybochko, M.E. Chaly, M.V. Yepifanova, N.D. Akhvlediani, A.O. Krasnov
Application of autoplasma enriched with platelet derived growth factor in the treatment of erectile dysfunction
|
№1 / 2015
|
Kh.S. Ibishev, I.A. Khripun, Z.R. Gusova, I.I. Belousov, A.A. Cherny, E.O. Dzantieva, M.I. Kogan
Problems of testosterone deficiency and erectile dysfunction in men (literature review)
|
№6 / 2014
|
S.I. Gamidov, R.I. Ovchinnikov, A.Yu. Popova
Sildenafil citrate in the treatment of men with erectile dysfunction
|
№6 / 2014
|
A.V. Kuzmenko, V.V. Kuzmenko, T.A. Gyaurgiev, D.E. Stroeva
Chronobiological aspects of the use of complex «neirodoz» in patients with erectile dysfunction
|
№5 / 2014
|
V.S. Saenko, A.Z. Vinarov, S.V. Pesegov
Hyperuricemia – risk marker of endothelial dysfunction in the development of erectile dysfunction
|
№4 / 2014
|
A.A. Volkov, M.I. Petrichko, N.V. Budnik
Daily intake of phosphodiesterase type 5 inhibitors – correction of erectile dysfunction and lower urinary tract symptoms in patients with bph
|
№4 / 2014
|
I.V. Damulin, Yu.M. Esilevsky
Erectile dysfunction: the current state of problem
|
№3 / 2014
|
S.V. Moskvin, L.P. Ivanchenko
Chronobiological approach to the treatment of patients with erectile dysfunction using a combination of local negative pressureand laser illumination
|
№3 / 2014
|
I.A. Korneev, T.A. Alekseeva, S.Kh. Al-Shukri, A.N. Bernikov, A.A.Erkovich, V.N. Zhuravlev, A.A. Kamalov, M.I. Kogan, V.N. Pavlov, D.Yu. Pushkar
Determinants of risk of the development of erectile dysfunction in the Russian Federation: analysis of epidemiological studies
|
№3 / 2014
|
S.O. Yudovsky, D.Yu. Pushkar
Correction of erectile dysfunction in patients undergoing radical prostatec- tomy
|
№2 / 2014
|
A.A. Tomilov, E.N. Golubtsova
Combined treatment of patients with lower urinary tract symptoms and erectile dysfunction
|
№5 / 2013
|
A.A. Volkov, M.I. Petrichko, N.V. Budnik
Correction of erectile dysfunction in patients with BPH using daily administration of tadalafil 5 mg against the background of combined drug therapy
|
№5 / 2013
|